Literature DB >> 12372829

Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.

David L Vanik1, Witold K Surewicz.   

Abstract

The critical step in the pathogenesis of transmissible spongiform encephalopathies (prion diseases) is the conversion of a cellular prion protein (PrP(c)) into a protease-resistant, beta-sheet rich form (PrP(Sc)). Although the disease transmission normally requires direct interaction between exogenous PrP(Sc) and endogenous PrP(C), the pathogenic process in hereditary prion diseases appears to develop spontaneously (i.e. not requiring infection with exogenous PrP(Sc)). To gain insight into the molecular basis of hereditary spongiform encephalopathies, we have characterized the biophysical properties of the recombinant human prion protein variant containing the mutation (Phe(198) --> Ser) associated with familial Gerstmann-Straussler-Scheinker disease. Compared with the wild-type protein, the F198S variant shows a dramatically increased propensity to self-associate into beta-sheet-rich oligomers. In a guanidine HCl-containing buffer, the transition of the F198S variant from a normal alpha-helical conformation into an oligomeric beta-sheet structure is about 50 times faster than that of the wild-type protein. Importantly, in contrast to the wild-type PrP, the mutant protein undergoes a spontaneous conversion to oligomeric beta-sheet structure even in the absence of guanidine HCl or any other denaturants. In addition to beta-sheet structure, the oligomeric form of the protein is characterized by partial resistance to proteinase K digestion, affinity for amyloid-specific dye, thioflavine T, and fibrillar morphology. The increased propensity of the F198S variant to undergo a conversion to a PrP(Sc)-like form correlates with a markedly decreased thermodynamic stability of the native alpha-helical conformer of the mutant protein. This correlation supports the notion that partially unfolded intermediates may be involved in conformational conversion of the prion protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372829     DOI: 10.1074/jbc.M207511200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments.

Authors:  Adrian C Apetri; Kosuke Maki; Heinrich Roder; Witold K Surewicz
Journal:  J Am Chem Soc       Date:  2006-09-06       Impact factor: 15.419

3.  The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.

Authors:  P G Purohit; R J Tate; E Pow; D Hill; J G Connolly
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

4.  Differential stability of the bovine prion protein upon urea unfolding.

Authors:  Olivier Julien; Subhrangsu Chatterjee; Angela Thiessen; Steffen P Graether; Brian D Sykes
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

5.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

Review 7.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

8.  NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features.

Authors:  Gregor Ilc; Gabriele Giachin; Mariusz Jaremko; Łukasz Jaremko; Federico Benetti; Janez Plavec; Igor Zhukov; Giuseppe Legname
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

9.  Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans.

Authors:  Shaoman Yin; Nancy Pham; Shuiliang Yu; Chaoyang Li; Poki Wong; Binggong Chang; Shin-Chung Kang; Emiliano Biasini; Po Tien; David A Harris; Man-Sun Sy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

10.  Loss of anti-Bax function in Gerstmann-Sträussler-Scheinker syndrome-associated prion protein mutants.

Authors:  Julie Jodoin; Micheal Misiewicz; Priya Makhijani; Paresa N Giannopoulos; Jennifer Hammond; Cynthia G Goodyer; Andréa C LeBlanc
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.